Menopausal hormone replacement therapy.
In this paper, the evolution of postmenopausal hormone replacement is reviewed, with an evidence-based approach and particular emphasis on the Heart and Estrogen/Progestin Replacement Study and Women's Health Initiative reports. This therapy will continue to evolve and have pertinence for women with menopausal symptoms and for osteoporosis prevention in selected patients.
Varner
R Edward
RE
Department of Obstetrics and Gynecology, Division of Medical Surgical Gynecology, University of Alabama at Birmingham, 618 20th Street South, NHB 219, Birmingham, AL 35233-7333, USA. evarner@uabmc.edu
D000368:Aged; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000592:standards*; D019317:Evidence-Based Medicine / Q000592:standards; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D017698:Postmenopause / Q000187:drug effects*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D014481:United States; D016387:Women's Health